Section of Nephrology,West Virginia University School of Medicine, and Center for Health Ethics and Law, Robert C. Byrd Health Sciences Center,West Virginia University, Morgantown, WV, USA.
Clin J Am Soc Nephrol. 2011 Sep;6(9):2313-7. doi: 10.2215/CJN.03960411.
When the US Congress created the End-Stage Renal Disease (ESRD) Program in 1972, it gave physicians the responsibility of determining which patients were "appropriate" for dialysis. Congress provided no guidance on who should be selected or how. Only five years later, Dr. Belding Scribner, the father of chronic dialysis, noted that there was a need for a "deselection committee" because virtually all criteria for dialysis patient selection had been slackened, if not abandoned. In 1991, the Institute of Medicine Committee to Study the Medicare ESRD Program recommended the development of a clinical practice guideline because they noted there were "an increasing number of [dialysis] patients with limited survival possibilities and relatively poor quality of life." In 2000, the Renal Physicians Association and the American Society of Nephrology heeded the Institute of Medicine committee's recommendation and published Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis. In 2010, prompted by a substantial body of new research evidence, the Renal Physicians Association published a second edition of this clinical practice guideline. This article describes the application of the ethical principles of respect for patient autonomy, beneficence, nonmaleficence, justice, and professional integrity, and the ethical process of shared decision-making in making decisions about starting, withholding, continuing, and stopping dialysis with patients and families. It urges examination of medical indications and identifies appropriate limits to shared decision-making when the burdens of dialysis can be predicted to substantially outweigh the benefits.
当美国国会于 1972 年创建终末期肾脏疾病(ESRD)计划时,它赋予了医生决定哪些患者“适合”接受透析的责任。国会没有提供关于应该选择谁或如何选择的指导。仅仅五年后,慢性透析之父贝尔丁·斯克里布纳博士指出,需要一个“淘汰委员会”,因为几乎所有透析患者选择的标准都已经放宽,如果没有放弃的话。1991 年,医学研究所研究医疗保险 ESRD 计划委员会建议制定临床实践指南,因为他们注意到“越来越多的[透析]患者生存可能性有限,生活质量相对较差。”2000 年,肾脏医师协会和美国肾脏病学会响应医学研究所委员会的建议,发表了《在适当开始和停止透析方面的共同决策》。2010 年,在大量新研究证据的推动下,肾脏医师协会发布了该临床实践指南的第二版。本文描述了在与患者及其家属就开始、停止、继续或停止透析做出决策时,应用尊重患者自主权、善行、不伤害、公正和专业诚信的伦理原则以及共同决策的伦理过程。它敦促检查医疗适应症,并在可以预测透析的负担将大大超过收益时确定共同决策的适当限制。